A comparative study of Glasgow-Blatchford score early combined with multi-disciplinary team and traditional consultation mode in the treatment of upper gastrointestinal bleeding
-
摘要: 目的 探讨Glasgow-Blatchford评分(Glasgow-Blatchford score,GBS)早期联合多学科协作诊疗模式(multi-disciplinary team,MDT)对比传统会诊模式救治急性上消化道出血的疗效。方法 选取2021年2月-2021年12月山东省青岛市第三人民医院急诊科收治的GBS≥6分的急性上消化道出血患者160例,以随机数字表法分为MDT组80例及对照组80例。MDT组患者立即启动MDT治疗方案,对照组采用传统会诊模式治疗上消化道出血。对2组患者的急诊内镜完成率、止血成功率、住院时间进行对比分析。随访1年,比较1年内再出血率及全因死亡率,并将年龄、性别、红细胞输注量、MDT管理、入院时GBS、肝肾功能、凝血指标、白蛋白、血常规相关指标、血糖、动脉血乳酸水平纳入回归分析,评价各变量与1年内全因死亡率的相关性。结果 MDT组的急诊内镜完成率、内镜下止血成功率均高于对照组,内镜完成时间、住院时间较对照组缩短,随访1年内再出血率及全因死亡率低于对照组,差异有统计学意义(P < 0.05)。单因素分析显示2组间红细胞输注量、MDT管理、血红蛋白水平、血小板计数、乳酸水平差异有统计学意义,将上述因素作为变量纳入多因素logistic回归分析,结果显示MDT管理是1年内全因死亡率的保护性因素,红细胞输注量是全因死亡率的高危因素。结论 基于GBS早期启动MDT模式救治急性上消化道出血的疗效优于传统会诊模式,可最大程度地保障患者的生命安全。
-
关键词:
- 多学科诊疗模式 /
- Glasgow-Blatchford评分 /
- 急性上消化道出血
Abstract: Objective To explore the efficacy of Blatchford score combined with multi-disciplinary team(MDT) in the early stage of acute upper gastrointestinal bleeding compared with the traditional consultation mode.Methods From February 2021 to December 2021, 160 cases of acute upper gastrointestinal bleeding with Glasgow-Blatchford(GBS) bleeding score ≥ 6 were selected from the emergency department of Qingdao Third People's Hospital, Shandong Province. They were divided into MDT group(80 cases) and control group(80 cases) by random number table. The MDT group patients immediately started the MDT treatment program, while the control group treated upper gastrointestinal bleeding with traditional consultation mode. The completion rate of emergency endoscopy, the success rate of hemostasis and the length of hospitalization of the two groups were compared and analyzed. oneyear, compare the rate of rebleeding and all-cause mortality within one year, and include age, sex, red blood cell infusion volume, MDT management, GBS score at admission, ALT, AST, PT, APTT, albumin, BUN, HGB, PLT, WBC, blood glucose, arterial blood lactic acid level into the regression analysis to evaluate the correlation between each variable and all-cause mortality within one year.Results The completion rate of emergency endoscopy and the success rate of endoscopic hemostasis in the MDT group were higher than those in the control group, the completion time of endoscopy and the hospitalization time were shorter than those in the control group, and the rebleeding rate and all-cause mortality rate within one year of follow-up were lower than those in the control group, the difference was statistically significant(P < 0.05). Univariate analysis showed that red blood cell infusion volume, MDT management, HGB level, PLT level, and lactic acid level were selected as variables, and then included in multivariate logistic regression analysis. The results showed that MDT management was a protective factor for all-cause mortality within one year, and red blood cell infusion volume was a high-risk factor for all-cause mortality.Conclusion The MDT mode based on GBS is better than the traditional consultation mode in the treatment of acute upper gastrointestinal bleeding, which can guarantee the life safety of patients to the greatest extent. -
-
表 1 2组患者临床资料比较
例(%) 指标 MDT组(n=80) 对照组(n=80) P 年龄/岁 62.0(55.0,70) 57.0(52.0,66.0) 0.89 男性 55(68.8) 50(62.5) 0.40 高血压 45(56.3) 38(47.5) 0.55 糖尿病 29(36.3) 23(28.8) 0.41 冠心病 21(26.3) 18(22.5) 0.69 发病时间/h 6.6±4.2 6.4±4.1 0.44 GBS评分/分 10.4±2.6 10.9±2.9 0.63 出血病因 0.92 消化性溃疡 40(50.0) 42(52.5) 胃底食管静脉曲张 21(26.3) 21(26.3) 其他 19(23.8) 17(21.3) 红细胞/(×1012/L) 3.24±1.14 2.73±1.06 0.34 血红蛋白/(g/L) 83.5±26.6 81.8±25.2 0.25 血小板/(×109/L) 114.2±76.5 105.6±83.3 0.12 APTT/s 15.8±26.6 81.8±25.2 0.25 PT/s 15.6±3.2 16.3±3.6 0.12 表 2 2组观察指标比较
例(%) 项目 急诊内镜率 内镜止血成功率 内镜完成时间/h 住院时间/d 院内再出血率(1年内) 全因死亡率(1年内) MDT组(n=80) 80(100.0) 76(95.0) 10(6,18) 7(5,10) 3(3.8) 16(20.0) 对照组(n=80) 70(87.5) 64(80.0) 18(10,22) 9(6,12) 10(12.5) 28(35.0) P < 0.05 < 0.05 < 0.05 < 0.05 0.04 0.03 表 3 全因死亡率的危险因素分析
变量 单因素分析 多因素分析 OR (95%CI) P OR (95%CI) P 年龄 1.01(0.99~1.02) 0.08 性别 1.02(0.62~1.70) 0.91 1.51(0.87~2.62) 0.14 红细胞输注量 1.45(1.03~2.05) 0.03 1.67(1.20~2.67) 0.02 GBS评分 1.23(0.61~2.49) 0.57 MDT 0.74(0.61~0.87) 0.02 0.79(0.63~0.84) 0.03 ALT 1.01(0.99~1.02) 0.09 AST 0.99(0.99~1.00) 0.43 PT 0.99(0.97~1.01) 0.25 APTT 1.02(0.98~1.07) 0.32 白蛋白 1.00(0.99~1.00) 0.91 BUN 0.85(0.59~1.22) 0.38 HGB 0.92(0.88~0.96) 0.01 0.93(0.85~1.02) 0.12 PLT 0.98(0.97~0.99) 0.04 0.99(0.99~1.01) 0.56 WBC 1.02(0.99~1.04) 0.24 血糖 1.03(0.96~1.09) 0.38 乳酸 1.16(1.00~1.36) 0.04 1.01(0.84~1.22) 0.88 -
[1] 中国医师协会急诊医师分会, 中华医学会急诊医学分会, 全军急救医学专业委员会, 等. 急性上消化道出血急诊诊治流程专家共识(2020版)[J]. 中华急诊医学杂志, 2021, 30(1): 15-24. doi: 10.3760/cma.j.issn.1671-0282.2021.01.006
[2] 刘海华, 蒋熙攘, 陈华, 等. 多学科诊疗模式医疗整合对急性上消化道出血紧急救治的疗效研究[J]. 临床急诊杂志, 2021, 22(8): 525-528. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202108003.htm
[3] 蒋彬, 曹婷, 阳学风, 等. 多学科协作诊疗模式在抢救危险性上消化道出血致失血性休克中的疗效研究[J]. 实用休克杂志(中英文), 2021, 5(4): 222-226. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYW202104009.htm
[4] 张瑞军, 戴晶, 杨桥, 等. 急性上消化道出血救治快速通道效果评价分析[J]. 临床急诊杂志, 2022, 23(12): 827-831. https://lcjz.whuhzzs.com/article/doi/10.13201/j.issn.1009-5918.2022.12.005
[5] Lu Y, Loffroy R, Lau JY, et al. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding[J]. Br J Surg, 2014, 101(1): e34-e50.
[6] 王连峰, 吴廷创. 顽固性上消化道出血多学科联合诊疗模式的探讨[J]. 中国医学创新, 2014, 11(20): 118-120. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX201420045.htm
[7] 田丹, 魏捷, 晏晨, 等. 以多学科协作为导向的重症上消化道大出血的急诊综合治疗[J]. 临床急诊杂志, 2019, 20(2): 136-138. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201902011.htm
[8] Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage[J]. Lancet, 2000, 356(9238): 1318-1321.
[9] 《中华消化外科杂志》编辑委员会, 《中华消化杂志》编辑委员会. 急性非静脉曲张性上消化道出血多学科防治专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(12): 1094-1100.
[10] Stanley AJ, Laine L, Dalton HR, et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study[J]. BMJ, 2017, 356: i6432.
[11] Abougergi MS, Charpentier JP, Bethea E, et al. A prospective, multicenter study of the AIMS65 score compared with the Glasgow-blatchford score in predicting upper gastrointestinal hemorrhage outcomes[J]. J Clin Gastroenterol, 2016, 50(6): 464-469.
[12] Sung JJ, Chiu PW, Chan FKL, et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018[J]. Gut, 2018, 67(10): 1757-1768.
[13] Kalkan Ç, Soykan I, Karakaya F, et al. Comparison of three scoring systems for risk stratification in elderly patients with acute upper gastrointestinal bleeding[J]. Geriatr Gerontol Int, 2017, 17(4): 575-583.
[14] Siau K, Hodson J, Ingram R, et al. Time to endoscopy for acute upper gastrointestinal bleeding: results from a prospective multicentre trainee-led audit[J]. United European Gastroenterol J, 2019, 7(2): 199-209.
[15] Lau JYW, Yu YY, Tang RSY, et al. Timing of endoscopy for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2020, 382(14): 1299-1308.
[16] Jeong N, Kim KS, Jung YS, et al. Delayed endoscopy is associated with increased mortality in upper gastrointestinal hemorrhage[J]. Am J Emerg Med, 2019, 37(2): 277-280.
[17] Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the international consensus group[J]. Ann Intern Med, 2019, 171(11): 805-822.
[18] Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding[J]. BMJ, 2019, 364: l536.
[19] de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752.
-